Clinical Trial Update: Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating cord blood treatment for neonatal hypoxic-ischemic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hypoxic Ischemic Encephalopathy

Drugs mentioned

• Cord blood infusion (cord blood-derived stem cells)

Snippet

Sponsor: Michael Cotten | Conditions: Neonatal Hypoxic Ischemic Encephalopathy | Phase 1 | Status: COMPLETED